WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock Ownership - Who owns Fennec Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fennec Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rosty RaykovDirector2026-06-019,747$9.62
$93.77kSell
Rosty RaykovDirector2026-06-0115,597$2.45
$38.21kBuy
Chris A. RallisDirector2026-05-118,346$7.04
$58.76kSell
Chris A. RallisDirector2026-05-1114,344$2.44
$35.00kBuy
Rosty RaykovDirector2026-05-0115,598$2.45
$38.22kBuy
Rosty RaykovDirector2026-05-0110,781$6.47
$69.75kSell
Rosty RaykovDirector2026-04-0115,598$2.45
$38.22kBuy
Rosty RaykovDirector2026-04-0110,946$6.31
$69.07kSell
Christiana Marie CioffiChief Strategy Officer2026-03-264,700$4.23
$19.88kBuy
Robert AndradeCHIEF FINANCIAL OFFICER2026-03-2613,072$5.10
$66.67kBuy

1 of 4

FENC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FENC insiders and whales buy or sell their stock.

FENC Shareholders

What type of owners hold Fennec Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Southpoint Capital Advisors LP583.66%202,744,741$1.86BInsider
Robert W. Butts358.44%124,512,000$1.14BInsider
Southpoint Master Fund LP11.51%3,997,214$36.73MInsider
Spa Essetifin11.50%3,993,694$36.70MInsider
Rosalind Advisors Inc8.37%2,908,201$26.73MInstitution
Southpoint Capital Advisors LP7.90%2,744,741$25.22MInstitution
Solas Capital Management LLC7.15%2,482,198$22.81MInstitution
Manchester Management Pr LLC6.29%2,184,023$20.07MInsider
Manchester Management Co LLC6.29%2,184,023$20.07MInsider
Aigh Capital Management LLC5.70%1,981,501$18.21MInstitution

1 of 3

FENC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FENC4.51%95.49%Net SellingNet Buying
PALI84.51%6.58%Net Buying
DMAC21.71%69.04%Net Buying
SLN14.05%0.09%
NVCT17.04%42.64%Net Buying
View Top Biotech Stocks

Fennec Pharmaceuticals Stock Ownership FAQ

Who owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals (NASDAQ: FENC) is owned by 46.64% institutional shareholders, 988.60% Fennec Pharmaceuticals insiders, and 0.00% retail investors. Southpoint Capital Advisors LP is the largest individual Fennec Pharmaceuticals shareholder, owning 202.74M shares representing 583.66% of the company. Southpoint Capital Advisors LP's Fennec Pharmaceuticals shares are currently valued at $1.82B.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.